Schizophrenia: all 3,539 studies
Page 16 of 36. Open to participants first (473), then studies with results posted, then the rest; newest registration first within each.
- Can Neural Network Instability in Schizophrenia be Improved With a Very Low Carbohydrate Ketogenic Diet?CompletedNCT05268809Not applicable
- The Difference of Grey Matter Volume Among the Patients of SchizophreniaCompletedNCT05262790
- The Effect of Psychoeducation on Healthy Lifestyle Behaviors in Individuals With SchizophreniaCompletedNCT05259748Not applicable
- Ginkgo Biloba Extract in the Treatment of SchizophreniaCompletedNCT05258123Not applicable
- Evaluation of the Role of Neurodegeneration in SchizophreniaCompletedNCT05257720
- Trial to Study the Effect of CVL-231 on 24-Hour Ambulatory Blood Pressure in Participants With SchizophreniaCompletedNCT05245539Phase 1
- Medication Reviews in Severe Mental IllnessCompletedNCT05243160Not applicable
- A Safety，Tolerability and Pharmacokinetics Clinical Trial of JX11502MA CapsuleStatus unknownNCT05233657Phase 1
- Effects of an Integrated Multimodal Lifestyle Intervention for Management of Violence in SchizophreniaCompletedNCT05229484Not applicable
- The Safety and Efficacy of Lurasidone In Subjects With Schizophrenia Switched From OlanzapineTerminatedNCT05213143Phase 4
- Plan D- Vitamin D Supplementation in Psychotic DisordersCompletedNCT05211635Not applicable
- The Effect of Psychoeducation Program on Healthy Living BehaviorsStatus unknownNCT05208021Not applicable
- Effects of Integrated Moral Reasoning Development Intervention for Management of Violence in SchizophreniaCompletedNCT05207319Not applicable
- Estimating Prevalence of Inherited Disorders of Sulfur Amino Acids Metabolism in Patients With Psychotic Disorders.CompletedNCT05206292Not applicable
- Luteolin for the Treatment of People With SchizophreniaCompletedNCT05204407Not applicable
- Electrical Brain Stimulation for Cognitive Impairment in Schizophrenia: a tDCS-fMRI StudyActive, not recruitingNCT05200962Phase 1
- Home-based Intervention With Semaglutide Treatment Of Neuroleptica-Related PrediabetesCompletedNCT05193578Phase 2
- Evaluate the Safety, Tolerability and Pharmacokinetic Profile of TPN672 Tablets Maleate in Patients With SchizophreniaStatus unknownNCT05192304Phase 1
- Study to Evaluate the Efficacy, Safety, and Tolerability of Luvadaxistat in Participants With Cognitive Impairment Associated With SchizophreniaTerminatedNCT05182476Phase 2
- Comparative Bioavailability of Risperidone.CompletedNCT05179525Phase 1
- Prevalence of Cardiovascular Disorders in Patients Aged 40 and More With SchizophreniaStatus unknownNCT05174533
- Real-life Assessment of Abilify Maintena + Rexult in SchizophreniaCompletedNCT05169268
- Study Evaluating the Efficacy and Safety of WID-RGC20(Cariprazine) in Patients With SchizophreniaStatus unknownNCT05168007Phase 3
- Exploration of the Deep Transcranial Magnetic Stimulation for Treatment Resistant SchizophreniaStatus unknownNCT05167942Not applicable
- REtinal and VIsual Cortical Response in Early PSYchosisTerminatedNCT05167396Not applicable
- Interest of EMDR Schizophrenic DisordersTerminatedNCT05164289
- Transcranial Alternating Current Stimulation (tACS) for Auditory HallucinationsStatus unknownNCT05159336Not applicable
- Effectiveness and Mechanisms of Recovery Oriented Cognitive TherapyWithdrawnNCT05140135Not applicable
- iTBS on Negative Symptoms and Cognitive Function in SchizophreniaCompletedNCT05137158Not applicable
- Efficacy Study of a New Individualized Rehabilitation Programme for Social Cognition in Patients With SchizophreniaCompletedNCT05130853Not applicable
- Cognitive Remediation Method by Rhythmic, Vocal and Embodied Musical Learning for Stabilized Schizophrenic PatientsCompletedNCT05124470Not applicable
- A Clinical Pharmacology Trial of Brexpiprazole Long Acting Injectable (LAI) Administered as a Single Dose in Patients With SchizophreniaWithdrawnNCT05119894Phase 1
- Insomnia in the Patient With Schizophrenic Disorder: Evaluation of a CBT and Psychoeducational InterventionCompletedNCT05115604Not applicable
- Journey Study: Evaluate the Efficacy, Safety, and Tolerability of Valbenazine as Adjunctive Treatment for SchizophreniaCompletedNCT05110157Phase 3
- The Impact of the Covid-19 Pandemic on Schizophrenia Patients Registered With the Community Mental Health CenterCompletedNCT05109572
- Peripheral Immune System in Individuals With SchizophreniaCompletedNCT05109065
- Pharmacokinetics of CVL-231 Following Single Oral Administration of Modified- and Immediate-release Formulations in Fasted and Fed Healthy ParticipantsCompletedNCT05106309Phase 1
- M1 Schizophrenia PET StudyCompletedNCT05105542Phase 1
- Animal-Assisted Therapy in the Residential Treatment of Schizophrenia and AddictionsCompletedNCT05103865Not applicable
- Theta-burst rTMS in Schizophrenia to Ameliorate Negative and Cognitive SymptomsCompletedNCT05100888Not applicable
- Program for the Introduction Into Clinical Practice of the Principles of Personalized and Preventive Medicine Based on the Isolation of Gene Polymorphism in Schizophrenia in People of the Kazakh Ethnic GroupCompletedNCT05090644
- cTBS on First-episode Drug Naive Patients With SchizophreniaStatus unknownNCT05086133Not applicable
- Clozapine Use Pattern in the Province of SevilleCompletedNCT05083377
- Pentoxifylline Add-on Therapy for SchizophreniaStatus unknownNCT05073640Phase 1/2
- The Effect of the Psychoeducation Program on the Subjective Well-being of CaregiversStatus unknownNCT05068765Not applicable
- Resting State Electroencephalogram for Psychotic DisordersStatus unknownNCT05065489
- Brain Stimulation, Clinical Symptoms and CognitionCompletedNCT05053451Not applicable
- D-serine AudRem: R33 PhaseSuspendedNCT05046353Phase 1/2
- Early Identification and Predictive Parsing for High Risk Group of SchizophreniaCompletedNCT05042739
- A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in SchizophreniaCompletedNCT05039489Not applicable
- Neurocognition After Perturbed SleepCompletedNCT05032963Not applicable
- Comparing Two Behavioral Approaches to Quitting Smoking in Mental Health SettingsCompletedNCT05030272Not applicable
- Cognitive Remediation for Social Cognition in Schizophrenia and Related DisordersCompletedNCT05017532Not applicable
- The Safety and Efficacy of Lurasidone With Different Initiation Dose in Chinese Acute Phase Patients With SchizophreniaCompletedNCT05011669Phase 4
- Cognitive Behaviour Therapy for Voices and DissociationCompletedNCT04990414Phase 2
- The Effects of Different Modalities of Exercise in Patients With SchizophreniaStatus unknownNCT04987151Not applicable
- Dynamics of Risk Perception and Risk Behavior in Alcohol Use Disorder and SchizophreniaStatus unknownNCT04985786Not applicable
- A Prospective, Open-ended, Multi-center Study of Schizophrenia Patients Switching to ZolodineTerminatedNCT04975035Phase 1/2
- Study to Assess the Safety and Pharmacokinetics of CY6463 in Participants With Stable SchizophreniaCompletedNCT04972227Phase 1
- Neural Correlates of Social Touch and Interoceptive Perception As Potential Biomarker for Impaired Social FunctioningCompletedNCT04968223
- Aging and Disease Course: Contributions to Lifespan Neurobiology of SchizophreniaActive, not recruitingNCT04951700
- Exploring Hand Function in People With Schizophrenia Based on Perspective of Sensorimotor ControlCompletedNCT04941677
- Motivational Interviewing in Patients With SchizophreniaCompletedNCT04941352Not applicable
- A Study to Assess the Treatment of Schizophrenia With Paliperidone Palmitate in Rwandan Healthcare SettingsCompletedNCT04940039Phase 4
- Effects of Music Beat on Motor Function in Individuals At Risk for Psychotic Onset and Schizophrenia PatientsCompletedNCT04929795Not applicable
- COG-PSYCHO : Social Cognition and Psychotic Characteristics: Genetic and Phenomic ApproachStatus unknownNCT04928053Not applicable
- Relative Bioavailability of LY03010 Compared to Listed DrugCompletedNCT04922593Phase 1
- The OPUS YOUNG Trial. Early Intervention Versus Treatment as Usual for Adolescents With First-episode PsychosisCompletedNCT04916626Not applicable
- Acceptance and Commitment Therapy-based Lifestyle Counselling Programme for Early Psychosis on Physical ActivityCompletedNCT04916496Not applicable
- Exploring the Effectiveness of Group Cognitive Stimulation Therapy in People With Schizophrenia.Status unknownNCT04916483Not applicable
- Aripiprazole Once-Monthly in Hospitalized Patients (INITIATE)Status unknownNCT04907279
- Face Your Fears: Cognitive Behavioural Virtual Reality Therapy for "Paranoia".CompletedNCT04902066Not applicable
- Adjunctive Use of Fute (Flupentixol) in Multi-acting Receptor-targeted Antipsychotics Treated Schizophrenia PatientsCompletedNCT04898270Phase 4
- Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication?Active, not recruitingNCT04892199Phase 4
- Feasibility of a Novel Process-based Treatment for Patients With PsychosisCompletedNCT04874974Not applicable
- RCT of tDCS Combined With Cognitive Training in SchizophreniaCompletedNCT04870996Not applicable
- Study of the Impact on the Therapeutic Alliance of a Short Initial Psychoeducation Programme in Patients With Early SchizophreniaCompletedNCT04867681Not applicable
- A Clinical Trial Study to Determine the Effect of an Investigational Drug (SEP-363856) Has on the Way That the Drug Metformin Travels Through the Body in People With Schizophrenia.CompletedNCT04865835Phase 1
- Developing Dual-channel Transcranial Alternating Current Stimulations Targeting Negative Symptoms in SchizophreniaCompletedNCT04859504Not applicable
- Targeting Individual Alpha Frequencies to Enhance Perceptual TimingCompletedNCT04856657
- Bioequivalence Study in Patients With Schizophrenia by Using Clozaril 100 mg Tablet (Clozapine) and WID-CLZ18CompletedNCT04849026Phase 1
- A Single Ascending Dose Study Of CY150112 After Single Oral Administration in Healthy Chinese SubjectsStatus unknownNCT04839926Phase 1
- A Clinical Trial to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic People With Schizophrenia, Followed by an Open-label Extension PhaseTerminatedNCT04825860Phase 2/3
- Safety, Biomarker Study of RL-007 in Subjects With SchizophreniaCompletedNCT04822883Phase 2
- The Effect of Psychoeducation Based on Uncertainty In Illness Theory On Schizophrenia CaregiversCompletedNCT04822051Not applicable
- Game-based Telehealth Therapeutic Intervention in First Onset PsychosisCompletedNCT04799717
- Motive-specific Intervention for Negative Symptoms in SchizophreniaStatus unknownNCT04793438Not applicable
- PET Trial to Evaluate Target Occupancy of CVL-231 on Brain Receptors Following Oral DosingCompletedNCT04787302Phase 1
- Effects of Auditory Stimulation on Sleep and Memory in SchizophreniaActive, not recruitingNCT04783571Not applicable
- Effect of Individual Cognitive Stimulation at Home in Adults With Psychotic DisordersCompletedNCT04783285Not applicable
- Virtual Group Fitness and Nutrition Intervention for Individuals With PsychosisCompletedNCT04783246Not applicable
- Study of the Effectiveness of Mental Contrasting and Implementation Intention in the Management of Apathy in SchizophreniaStatus unknownNCT04781179Not applicable
- Music Therapy for People With Schizophrenia and Relates Psychosis.CompletedNCT04777266Not applicable
- Efficacy of Computer-assisted Cognitive Remediation in Patients With SchizophreniaCompletedNCT04773171Not applicable
- Auditory Processes and Emotional Perception in SchizophreniaCompletedNCT04768335Not applicable
- The Outcomes Among Persons With Schizophrenia Under the Peer-support Service in Vocational Rehabilitation ProgramCompletedNCT04767204Not applicable
- Vildagliptin for Treatment of Antipsychotic-induced DyslipidemiaWithdrawnNCT04761861Phase 2
- Examining Strategy Monitoring and Remediation TrainingCompletedNCT04756388Not applicable
- Differences in Schizophrenia With One-month and 3-month Paliperidone Palmitate TreatmentCompletedNCT04754750Phase 1/2
- Virtual Cognitive Behavioural Therapy for PsychosisCompletedNCT04752449Not applicable